Tech Center 1600 • Art Units: 1649 1675
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19346638 | STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF | Non-Final OA | Merck Sharp & Dohme LLC |
| 17623192 | METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE | Final Rejection | The Regents of the University of California |
| 16755198 | A Cell-Based Seeding Assay for Huntingtin Aggregation | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17568619 | BK CHANNEL-MODULATING PEPTIDES AND THEIR USE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17783505 | CD122 WITH ALTERED ICD STAT SIGNALING | Non-Final OA | Synthekine, Inc. |
| 17184758 | PREVENTING AND TREATING AMYLOID- BETA DEPOSITION BY STIMULATION OF INNATE IMMUNITY | Non-Final OA | NEW YORK UNIVERSITY |
| 17535059 | COMPOUNDS AND METHODS TARGETING HUMAN TAU | Non-Final OA | Eli Lilly and Company |
| 17211163 | COMBINATION THERAPY | Non-Final OA | Eli Lilly and Company |
| 17322482 | RGMa BINDING PROTEIN AND USE THEREOF | Non-Final OA | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY |
| 17459835 | ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF | Non-Final OA | Alector LLC |
| 17182095 | MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF | Non-Final OA | ABBVIE DEUTSCHLAND GMBH & CO KG |
| 17031349 | ANTI-CLEVER-1 AGENTS FOR CONTROLLING LYSOSOMAL VATPASE PROTON PUMPS TO INCREASE LYSOSOMAL PH-VALUE AND THE CROSS-PRESENTATION OF DIGESTED MATTER | Non-Final OA | Faron Pharmaceuticals Oy |
| 17461862 | METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS | Non-Final OA | OLIGOMERIX, INC. |
| 17679723 | AMYLOID CONJUGATE AND USES AND METHODS THEREOF | Final Rejection | ARACLON BIOTECH, S.L. |
| 16985387 | METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID BETA PEPTIDES | Final Rejection | ARACLON BIOTECH, S.L. |
| 17634688 | ENGINEERED INTERLEUKIN-2 RECEPTOR BETA AGONISTS | Non-Final OA | Elpis Biopharmaceuticals |
| 17535029 | TEST KITS, DEVICES AND METHODS FOR DETECTING INFECTION | Non-Final OA | Maxim Biomedical, Inc. |
| 17378897 | METHOD FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS | Non-Final OA | Citryll B.V. |
| 17253569 | ANTIBODY MOLECULES TO COMPLEMENT COMPONENT 5 AND USES THEREOF | Non-Final OA | Atarga, LLC |
| 16619317 | COMPOSITIONS AND METHODS FOR INHIBITING AMYLOID ACCUMLATION AND TAU AGGREGATION | Non-Final OA | OHIO STATE UNIVERSITY |
| 16282943 | HIGH SENSITIVITY IMMUNOASSAYS AND KITS FOR THE DETERMINATION OF PEPTIDES AND PROTEINS OF BIOLOGICAL INTEREST | Non-Final OA | Araclon Biotech |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy